126 related articles for article (PubMed ID: 1723537)
1. The cure of leukemia: a model for the role of humoral growth factors in cancer treatment.
Burke PJ
Semin Hematol; 1991 Jul; 28(3 Suppl 4):48-53. PubMed ID: 1723537
[No Abstract] [Full Text] [Related]
2. Cytokine-mobilized peripheral blood progenitor cells.
Nemunaitis J
Semin Oncol; 1996 Apr; 23(2 Suppl 4):9-14. PubMed ID: 8600547
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic growth factors in cancer chemotherapy.
Morstyn G; Lieschke GJ
Cancer Chemother Biol Response Modif; 1994; 15():367-90. PubMed ID: 7540031
[No Abstract] [Full Text] [Related]
5. Colony-stimulating factors in cancer therapy.
Morstyn G; Sheridan WP
Cancer Chemother Biol Response Modif; 1992; 13():308-26. PubMed ID: 1382528
[No Abstract] [Full Text] [Related]
6. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
7. In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.
Herrmann F; Brugger W; Kanz L; Mertelsmann R
Semin Oncol; 1992 Aug; 19(4):422-31. PubMed ID: 1380732
[No Abstract] [Full Text] [Related]
8. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
9. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
11. Rapid and sustained allogeneic transplantation using immunoselected CD34(+)-selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony-stimulating factors.
Corringham RE; Ho AD
Blood; 1995 Sep; 86(5):2052-4. PubMed ID: 7544651
[No Abstract] [Full Text] [Related]
12. Hematopoietic effects and clinical application of granulopoietic growth factors.
Höglund M
Ups J Med Sci; 1996; 101(2):121-48. PubMed ID: 8897704
[No Abstract] [Full Text] [Related]
13. Thrombopoietic factors potentially useful in the treatment of acute leukemia.
Archimbaud E; Thomas X
Leuk Res; 1998 Dec; 22(12):1155-64. PubMed ID: 9922079
[TBL] [Abstract][Full Text] [Related]
14. Biological therapies in bone marrow transplantation.
Kochupillai V
Indian J Med Res; 1995 Apr; 101():129-33. PubMed ID: 7538493
[TBL] [Abstract][Full Text] [Related]
15. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).
Lieschke GJ; Burgess AW
N Engl J Med; 1992 Jul; 327(1):28-35. PubMed ID: 1375975
[No Abstract] [Full Text] [Related]
17. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
Aglietta M; Pasquino P; Sanavio F; Stacchini A; Severino A; Fubini L; Morelli S; Volta C; Monteverde A; Piacibello W
Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
[TBL] [Abstract][Full Text] [Related]
18. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
19. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
Akabutu JJ; Chan JR
Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
[No Abstract] [Full Text] [Related]
20. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients?
Mandelli F; Petti MC
Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
